chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came into Public Health office on 2/4/2011 c/o continuing right arm pain and weakness since receiving her influenza vaccine on 10/14/2010. Patient interviewed via translator, PHA. Pt. stated she had pain in right arm immediately after receiving vaccine, then redness, swelling and fever on the same date. She states the fever continued for a month. She states the pain has been continuous since the vaccination, and that she also has right arm weakness for the past three months. She states she has been seeing a healthcare provider for treatment of her pain, but that the medication is not improving her condition. She states the healthcare provider referred her to this Public Health Department. The healthcare providers that have seen her for this condition are NP, and Dr; both practice at same office. The patient does not know the name of the medication prescribed or beginning dates of treatment by these healthcare providers. She authorized a release of information, allowing health department to obtain medical records. She was also directed to continue treatment as her physician had directed her, to avoid straining the arm, and to seek medical attention should her condition change or worsen.
Extended minor menstrual flow since first dose. Continued thru second dose.   My cycle is usually first week of month only and only 1 to 3 days regular flow.    This is just a minor flow. Not spotting but not regular either
Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  near syncope, hypotension, diaphoresis. Vaccine was administered at 1510   Assessment : Time of assessment 1524 . Pt stated she began to feel like she was going to pass out. She was diaphoretic, clammy, and hypotensive upon assessment. Vitals at 1525 were; BP 63/40, HR 40, OXYGEN 99%, RR-16. Orthostatic VS were completed upon EMS arrival at 1553; BP 153/88, HR 73, OXYGEN 100%.    Actions taken:  Vitals sign taken  EMS called at  1530. VAERS form obtained and completed by RN. Hand off to EMS upon arrival at 1550.  Upon assessment of patient
Administration of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medication was  reported.
4 hrs after vaccination, pt reported high temp of 103-104 and "hard knot" where injection was given in left deltoid. Next morning his left arm was red, hot, edematous from his shoulder to his elbow. Seen in clinic 4 days after vaccination. Treated with Celphelaxin 500mg  4 times daily x 7 days. F/U 6/21/18 showed all symptoms resolved except there remains a small firm round area at the site of the injection.
Information has been received from a registered nurse concerning a 32 year old male who on Dec 7 2005 was vaccinated IM in the left deltoid with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). On Dec 12 2005, 72 hours post vaccination, the patient experienced pain, swelling from the left deltoid to just above the elbow, and flu like symptoms. Subsequently, the patient fully recovered. Unspecified medical attention was sought. There was no product quality complaint. It was noted that the nurse requested a lot check on lot # 651318/1006P. The events were considered to be disabling. Additional information has been requested.
Patient developed urticarial rash, fatigue, pruritis approx 12 hours after recieving vaccination.
Patient developed chest pain symptoms on the evening of 5/13, he said symptoms waxed and waned but worsened on 5/16 which prompted him to go the Hospital ER.  There he was found to have an elevated troponin 27.9 and ST elevations on ECG.  This prompted an emergent evaluation by cardiology and patient underwent a Left Heart Catherization  (LHC) on 5/16 which showed no obstructive disease.  Cardiology suspected possible myocarditis which was confirmed on 5/18 with a cardiac MRI.  Patient also had an echocardiogram that showed mildly reduced systolic function EF 50-55% and mild hypokinesis in the left ventricle (echo obtained on 5/17).  Patient was discharged on two new medications: Losartan and metoprolol and has cardiology follow up on June 1.
Right thigh began with itching with shot sight Saturday night, Sunday had red, raised bump size of baseball. Has 3cm x 2cm red, raised area in close proximity to shot sight. Swollen lymph node in right groin.
shoulders weakness , knees and hip weakness; fell once already stepping down a curve; had pain, every day and had to take pain medication each day; unable to stand for a long period of time; walking is slow; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 02Mar2021 12:45 (Batch/Lot number was not reported) at the age of 66 years old, as 1ST DOSE, SINGLE for COVID-19 immunisation. Medical history included blood pressure abnormal and blood cholesterol abnormal. The patient was not pregnant at the time of vaccination. Concomitant medications received within 2 weeks of vaccination included atorvastatin; and amlodipine; both taken for an unspecified indication, start and stop date were not reported. No other vaccine received in four weeks. The patient had shoulders weakness, knees and hip weakness. She was unable to stand for a long period of time. Her walking was slow. She fell once already stepping down a curve. She had pain, every day and had to take pain medication each day. The patient used to be a very active person. The events occurred on 02Mar2021 12:45 PM. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was hospitalized due to shoulders weakness, knees and hip weakness for 3 days. Treatment for the events included IV, and pain medicine. The patient has not recovered from the events. The patient was tested for COVID-19 post vaccination on 16Mar2021 and result was negative. Prior to vaccination, the patient was not diagnosed with COVID-19.   Information on the batch/lot number has been requested.
I got painful skin sensitivity on the left side of my neck and upper shoulder area.; I got painful skin sensitivity on the left side of my neck and upper shoulder area.; a large muscle knot nearby, which showed up after the nerve pain.; a large muscle knot nearby, which showed up after the nerve pain.; This is a spontaneous report from a contactable consumer (patient herself). A 35-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6202, expiry date: unknown) via unspecified route of administration, in left arm on 23Mar2021 15:45 (age at vaccination: 35-years) as dose 1, single for covid-19 immunisation. Vaccination facility type was hospital. Patient was not pregnant at the time of vaccination. Patient had no known allergies. Patients medical history was none. Concomitant medications included multivitamin, fish oil, probiotics, advil, pepcid taken in two weeks, taken for unspecified indication, start and stop date not reported. No other vaccines was administered to patient in four weeks. On 30Mar2021 08:00, 6-7 days after first vaccine patient got painful skin sensitivity on the left side of my neck and upper shoulder area. Doctor also found a large muscle knot nearby, which showed up after the nerve pain. The AE results in Doctor or other healthcare professional office/clinic visit. Treatment was given for the adverse events with muscle relaxers, advil, massage, heat, and waiting. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of event was unknown.   No follow-up attempts are possible. No further information is expected.
Apnea and suspicious seizure activity requiring intubation, and transfer to NICU.
30 min after shot: fatigue, light headed, sore arm 8-10 hours after shot: light headed, dizzy, felt loopy, sore arm 24 hours after shot: sore arm, fever, chills, fatigue, facial pain 48 hours after shot: sore arm, fever, chills, fatigue, facial/head pain, nausea, stomach pain 72 hours after shot: no side effects 96 hours after shot: fatigue, chills, chest tight 5 days after shot: no side effects  6 days after shot: fatigue, chills, chest tight, migraine/facial pain, fever, stomach pain and nausea 7 days after shot: no side effects
This spontaneous report as received from a nurse regarding an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On 30-JUL-2015, the patients were vaccinated with improperly stored RECOMBIVAX HB lot # J013370, expiration date 03-FEB-2016 and lot number J0110613, expiration date 11-JUN-2015. No concomitant medication was reported. No adverse event was reported. No PWC (product quality complaint was involved). The outcome of the event was unknown. This is one of several reports receive from the same reporter. Additional information has been requested.
Pt recvd Recombivax HB vax 14JAN88 & 12FEB88 lab eval revealed Hep B surface Antigen neg, Hep B surface Antibody pos, Hep B core Antibody pos & nl liver function tests; Reporting MD felt pts exp was poss due to vax w/Hep B;
Patient was vaccinated with Pfizer #1 on 3/4/2021. She signed up, with the system the Agency for shot #2 and was allowed to come on a Moderna-only day, and was vaccinated a second time with Moderna #2 on 4/12/2021. No adverse outcomes or symptoms reported; counseled by Agency that she does not need additional vaccine. Troubleshooting: The patient did not present her vaccine card at the time of vaccine; scribe and vaccinator did not ask to see her card or call the troubleshooting line; screeners at the beginning of the process did not ask or turn her away on a Moderna-only day.
Swelling; redness; soreness down to the elbow; This is a spontaneous report from a contactable consumer (patient herself). A 71-year-old female patient, not pregnant, received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on the left arm, on 25Jan2021 11:00, at single dose, for covid-19 immunization. The patient has no medical history. Concomitant medications included estradiol (VAGIFEM) and, vitamins. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The vaccine was administered in the hospital. The patient experienced swelling; redness; and soreness down to the elbow - all on 01Feb2021. The patient had not recovered from these adverse events and; no treatment was received for them. The patient has not been tested for COVID-19 since the vaccination.  Information about the lot/batch number has been requested.
kind of flu feeling; Didn't feel well; Feeling like being hit by a car/you are weighted down/you worked out too hard; Case reference number US-BN-2021-002508 is a spontaneous case report initially received from a consumer via Agency (reference number USBAV21-0605) on 07-Dec-2021 and concerns a female patient.  The patient's medical history and concomitant medication details were not provided.   It was reported that the patient was previously vaccinated with RabAvert (unspecified dates).  On 04-Dec-2021, the patient was vaccinated with the first dose of RabAvert (inactivated rabies virus vaccine; batch number was not provided), at a dose reported as one shot via unknown route of administration, for post-exposure immunization.   On an unspecified date, after an unknown time after vaccination, the patient was feeling like being hit by a car. It wasn't like an allergic reaction, but the patient just didn't feel well. It had been on and off like she worked out too hard and was weighted down, kind of a flu feeling, as reported.  There was no treatment given due to the adverse event.  The outcome for the events was not provided.   At the time of this report, it was unknown whether the patient received the second dose of RabAvert.  All the events were assessed as non-serious and as related to Rabipur.  Additional information received from regulatory authority on 03-Dec-2021 included the local RA case ID.  No further information was provided.; Reporter's Comments: A female patient was vaccinated with the first dose of RabAvert at a dose reported as one shot via unknown route of administration, for post-exposure immunization. On an unspecified date, after an unknown time after vaccination, the patient experienced influenza-like symptoms, malaise and abnormal feeling. Influenza-like symptoms are listed for RabAvert per Datasheet, whilst malaise and abnormal feeling are listed as non-specific events per company convention. The patient's medical history and concomitant medication details were not provided. Due to implied temporal relationship, the causality is assessed as related to RabAvert for all three events. The case is non-serious.; Sender's Comments: A female patient was vaccinated with the first dose of RabAvert at a dose reported as one shot via unknown route of administration, for post-exposure immunization. On an unspecified date, after an unknown time after vaccination, the patient experienced influenza-like symptoms, malaise and abnormal feeling. Influenza-like symptoms are listed for RabAvert per Datasheet, whilst malaise and abnormal feeling are listed as non-specific events per company convention. The patient's medical history and concomitant medication details were not provided. Due to implied temporal relationship, the causality is assessed as related to RabAvert for all three events. The case is non-serious.
BAD CASE OF COVID; A spontaneous report has been received from a consumer concerning a female patient (age not provided) of Unknown ethnic origin.    The patient's past and current medical history included autism (ongoing). The following demography was reported for the patient's parent:   Sex: Unknown    No concomitant products were reported.    The patient received FluMist Quadrivalent (influenza vaccine live reassort 4v) (batch number Unknown) once/single administration, via nasal route for flu vaccination on an unknown date. The patient received FluMist Quadrivalent (influenza vaccine live reassort 4v) (batch number UNKNOWN) once/single administration, via nasal route for flu vaccination on an unknown date.     A Unknown administered Flumist Quadrivalent. No malfunction has been reported for this combination product.   A Unknown administered Flumist Quadrivalent. No malfunction has been reported for this combination product.    On an unknown date, the patient experienced bad case of covid (preferred term: COVID-19).     The outcome of the event was unknown.    The event was considered non-serious.     Device Information:     Combination Product Report: Yes    Product As Reported: FLUMIST QUADRIVALENT  Common Device Name: Nasal Spray  Procode: CCQ  Product Role: Suspect    Product As Reported: FLUMIST QUADRIVALENT  Common Device Name: Nasal Spray  Procode: CCQ  Product Role: Suspect
Allergic to that one chemical present in moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (Polyethylene glycol).    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine). At the time of the report, ALLERGY TO VACCINE (Allergic to that one chemical present in moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Covid-19 R06.02 - Shortness of breath E11.9 - Diabetes (CMS/HCC) J18.9 - Multifocal pneumonia U07.1, J12.82 - Pneumonia due to COVID-19 virus
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis. On an unknown date, the patient received Flu vaccine at an unknown dose. On an unknown date, less than a week after receiving Flu vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to Flu vaccine. Additional information was reported as follows: The age at vaccination was not reported. The patient stated that she always reponded to the shots by experiencing a sore arm within 24 to 48 hours after vaccination. This case was linked with US2018179211 case reported by the same reporter.
Patient had mild dizziness on Saturday but she said she had similar adverse reaction from her previous moderna (monovalent) shots.  Hives and itchness started on Sunday night. It started from her lower extremity but now it is all over her body.
HEADACHE, SENSITIVITY TO LIGHT, FEVER, CHILLS, NAUSEOUS, SWELLING OF INJECTION SITE, SWELLING OF ARMPIT AND LEFT BREAST, BRUISING UNDER ARMPIT (ON DAY 4 AFTER INJECTION).  SYMPTOMS LASTED 48 HOURS WITH TENDERNESS AND BRUISING STILL PRESENT.
Headache, Myalgia, Fever, Temperature of 100.7 Degrees F.  Narrative:
bumps in her face, ears (improved) and nose; i do experience a little pain when it rains; This is a spontaneous report from a contactable healthcare professional and consumer. A 63-year-old female patient received BNT162B2 (BNT162B2, PFIZER COVID-19 Vaccine, Soultion for injection, Batch/lot number and expiration date: was not reported), via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced small bumps in her face on an unspecified date. i do experience a little pain when it rains on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible.; information about lot/batch no cannot be obtained.
Approximately 14-15 hours after injection, my bellybutton bled about 1-2 tsp and then stopped.
Burning sensation, ache joints and bones, acid reflux, Agitation, Anxiety, arthritis, blood pressure high, high cholesterol, concentration, eyes, memory failure, difficulty, trouble remembering recent information, masturbation loss, migraine, insomnia, suicide attempt.
3 weeks post vaccination patient developed chest pain and shortness of breath. Was able to tolerate symptoms, then had radiation treatment and developed more shortness of breath. Was transported via EMS to hospital where an xray and MRI were completed and showed multiple blood clots in her lungs. Venous Doppler was also completed and blood clots were found in her legs. She was subsequently admitted to hospital.
I am still getting daily headaches/migraines that have worsened since receiving the vaccine. I have blurry vision, dizziness and feelings of weakness and confusion. I saw my neurologist, she increased the amount of Botox, that I already receive, to a stronger dose. She also added Cymbalta and promethazine to my prescriptions to take. Even with the increase and added prescriptions, I do not have any relief. I had a cat scan and an MRI of my brain. I was given an antibiotic and steroid, from the urgent care and that has not helped either. Another CT scan was performed. Those results were normal. I have a follow up on 08/24/2021 with my neurologist.
Information has been received from a physician concerning an approximately 8 year old male pt who was vaccinated with varicella vaccine live (date not reported). The patient's siblings had also been vaccinated with varicella virus vaccine live. On approximately 12/13/01, the pt developed herpes zoster. The pt was treated with acyclovir on 12/14/01 and did not have any further lesion development  as of 12/15/01. The physician reported that the herpes zoster was located at dermatome T2; however, he had counted 28 additional lesions outside the dermatome. A swab specimen was collected from a vesicular lesions. It was noted that there was no known recent exposure to wild-type virus (WTV) varicella zoster virus (VZV), and that the pt was doing well. Additional information has been requested.
Profuse sweating started 8 hours after having injection.  Fever, muscle aches, sore arm, weak, fell, an all over sick feeling, no appetite, dry cough, head congestion, elevated heart rate, around 100, highest I detected was 121.  Injection was on Monday, Sept 27th, I was down the entire day, the 28th.  All the symptoms remained on the 28th.  On the 29th, arm soreness was less, no fever, dry cough and head congestion were gone.  All over sick feeling was not as intense.
woke up with severe vertigo lasting 4 days, debilitating- could not get out of bed and would be intermittant in onset for 4 day period lasting from 30 sec to 5 min
Patient received a PREVNAR vaccine on Monday. The following day she developed a increasingly red, enlarging, tender rash on the injection site. She reports mild fatigue but no fever or chills. No cough or shortness of breath. She denies any joint symptoms. Given 7 days of cephalexin PO, pt returned 7/3 to report that rash seemed to be increasing and was changed to different abx (Bactrim). Patient presented back to PCP 7/5 and rash was resolving, tolerating abx well.
This spontaneous prospective pregnancy report was received from a nurse refers to a 26 year old female patient. The patient's medical history, concurrent conditions and concomitant therapies were reported as "none". The patient became pregnant with last menstrual period (LMP) of 14-JUL-2016 and estimated date of delivery (EDD) of 20-APR-2017, based on the date of the report. The pregnancy outcome was pending and the fetal outcome was unknown. On 22-DEC-2016, at 23 weeks of pregnancy, the patient was vaccinated inadvertently with the third dose of GARDASIL 9, intramuscularly (strength, dose, lot number and expiration date were not provided) for prophylaxis. Initial exposure to GARDASIL 9 was unknown as well as the date of the second dose. It was reported that the patient sought medical attention but no adverse events were reported. It was reported that the patient did not receive a treatment and labs were not performed. There was no product quality complaint (PQC) involved. At the time of reporting, the outcome of exposure during pregnancy was unknown. Additional information has been requested.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning an unknown number of patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On unknown dates over the past year, the patients were administered with improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This one of several reports received from the same source. Additional information has been requested.